No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19

DOI record: { "DOI": "10.1016/j.ijid.2020.12.060", "ISSN": [ "1201-9712" ], "URL": "http://dx.doi.org/10.1016/j.ijid.2020.12.060", "alternative-id": [ "S1201971220325832" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19" }, { "label": "Journal Title", "name": "journaltitle", "value": "International Journal of Infectious Diseases" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.ijid.2020.12.060" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases." } ], "author": [ { "affiliation": [], "family": "Sands", "given": "Kenneth", "sequence": "first" }, { "affiliation": [], "family": "Wenzel", "given": "Richard", "sequence": "additional" }, { "affiliation": [], "family": "McLean", "given": "Laura", "sequence": "additional" }, { "affiliation": [], "family": "Korwek", "given": "Kimberly", "sequence": "additional" }, { "affiliation": [], "family": "Roach", "given": "Jonathon", "sequence": "additional" }, { "affiliation": [], "family": "Miller", "given": "Karla", "sequence": "additional" }, { "affiliation": [], "family": "Poland", "given": "Russell E.", "sequence": "additional" }, { "affiliation": [], "family": "Burgess", "given": "L. Hayley", "sequence": "additional" }, { "affiliation": [], "family": "Jackson", "given": "Edmund", "sequence": "additional" }, { "affiliation": [], "family": "Perlin", "given": "Jonathan B.", "sequence": "additional" } ], "container-title": "International Journal of Infectious Diseases", "container-title-short": "International Journal of Infectious Diseases", "content-domain": { "crossmark-restriction": true, "domain": [ "ijidonline.com", "clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2021, 1, 1 ] ], "date-time": "2021-01-01T22:17:46Z", "timestamp": 1609539466000 }, "deposited": { "date-parts": [ [ 2021, 6, 12 ] ], "date-time": "2021-06-12T12:51:40Z", "timestamp": 1623502300000 }, "indexed": { "date-parts": [ [ 2023, 10, 3 ] ], "date-time": "2023-10-03T18:32:59Z", "timestamp": 1696357979843 }, "is-referenced-by-count": 5, "issued": { "date-parts": [ [ 2021, 3 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 3, 1 ] ], "date-time": "2021-03-01T00:00:00Z", "timestamp": 1614556800000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 12, 21 ] ], "date-time": "2020-12-21T00:00:00Z", "timestamp": 1608508800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S1201971220325832?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S1201971220325832?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "34-40", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 3 ] ] }, "published-print": { "date-parts": [ [ 2021, 3 ] ] }, "publisher": "Elsevier BV", "reference": [ { "author": "Bhimraj", "key": "10.1016/j.ijid.2020.12.060_bib0005", "series-title": "Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19", "year": "2020" }, { "author": "Borba", "journal-title": "medRxiv", "key": "10.1016/j.ijid.2020.12.060_bib0010", "volume": "2020", "year": "2020" }, { "DOI": "10.1056/NEJMoa2019014", "article-title": "Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19", "author": "Cavalcanti", "doi-asserted-by": "crossref", "first-page": "2041", "issue": "21", "journal-title": "New England Journal of Medicine", "key": "10.1016/j.ijid.2020.12.060_bib0015", "volume": "383", "year": "2020" }, { "author": "Centers for Disease Control and Prevention", "key": "10.1016/j.ijid.2020.12.060_bib0020", "series-title": "Coronavirus Disease 2019 (COVID-19) Cases in U.S", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30211-7", "article-title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "507", "issue": "10223", "journal-title": "Lancet", "key": "10.1016/j.ijid.2020.12.060_bib0025", "volume": "395", "year": "2020" }, { "author": "Clinicaltrials.gov", "key": "10.1016/j.ijid.2020.12.060_bib0030", "series-title": "Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105932", "article-title": "Chloroquine and hydroxychloroquine as available weapons to fight COVID-19", "author": "Colson", "doi-asserted-by": "crossref", "first-page": "105932", "issue": "4", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.ijid.2020.12.060_bib0035", "volume": "55", "year": "2020" }, { "author": "Food and Drug Administration", "key": "10.1016/j.ijid.2020.12.060_bib0040", "series-title": "Fact sheet for health care providers emergency use authorization (EUA) of hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of covid-19 in certain hospitalized patients", "year": "2020" }, { "author": "Food and Drug Administration", "key": "10.1016/j.ijid.2020.12.060_bib0045", "series-title": "FDA Drug Safety Communication: FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems", "year": "2020" }, { "DOI": "10.1016/j.tmaid.2020.101663", "article-title": "Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study", "author": "Gautret", "doi-asserted-by": "crossref", "journal-title": "Travel Med Infect Dis", "key": "10.1016/j.ijid.2020.12.060_bib0050", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105949", "article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", "author": "Gautret", "doi-asserted-by": "crossref", "first-page": "105949", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.ijid.2020.12.060_bib0055", "year": "2020" }, { "DOI": "10.1056/CAT.19.1036", "article-title": "Accelerating the Clinical Workflow Using the Sepsis Prediction and Optimization of Therapy (SPOT) Tool for Real-Time Clinical Monitoring", "author": "Guy", "doi-asserted-by": "crossref", "issue": "3", "journal-title": "NEJM Catalyst", "key": "10.1016/j.ijid.2020.12.060_bib0060", "volume": "1", "year": "2020" }, { "article-title": "Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review", "author": "Hernandez", "journal-title": "Ann Internal Med", "key": "10.1016/j.ijid.2020.12.060_bib0065", "year": "2020" }, { "DOI": "10.1128/AAC.01509-08", "article-title": "Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice", "author": "Keyaerts", "doi-asserted-by": "crossref", "first-page": "3416", "issue": "8", "journal-title": "Antimicrob Agents Chemother", "key": "10.1016/j.ijid.2020.12.060_bib0070", "volume": "53", "year": "2009" }, { "DOI": "10.1016/j.jaci.2020.04.006", "article-title": "Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan", "author": "Li", "doi-asserted-by": "crossref", "journal-title": "J Allergy Clin Immunol", "key": "10.1016/j.ijid.2020.12.060_bib0075", "year": "2020" }, { "author": "Massachusetts General Hospital, & National Heart, L. and Blood Institute (NHLBI)", "key": "10.1016/j.ijid.2020.12.060_bib0080", "series-title": "Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (ORCHID)", "year": "2020" }, { "DOI": "10.1016/j.medmal.2020.03.006", "article-title": "No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection", "author": "Molina", "doi-asserted-by": "crossref", "journal-title": "Médecine et Maladies Infectieuses", "key": "10.1016/j.ijid.2020.12.060_bib0085", "year": "2020" }, { "author": "National Institute of Allergy and Infectious Diseases (NIAID)", "key": "10.1016/j.ijid.2020.12.060_bib0090", "series-title": "Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons with COVID-19", "year": "2020" }, { "author": "National Institutes of Health", "key": "10.1016/j.ijid.2020.12.060_bib0095", "series-title": "COVID-19 Treatment Guidelines", "year": "2020" }, { "DOI": "10.1093/cid/ciaa394", "article-title": "Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients", "author": "Perinel", "doi-asserted-by": "crossref", "journal-title": "Clin Infect Dis", "key": "10.1016/j.ijid.2020.12.060_bib0100", "year": "2020" }, { "DOI": "10.1001/jama.2020.6775", "article-title": "Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area", "author": "Richardson", "doi-asserted-by": "crossref", "journal-title": "JAMA", "key": "10.1016/j.ijid.2020.12.060_bib0105", "year": "2020" }, { "article-title": "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China", "author": "Ruan", "journal-title": "Intens Care Med", "key": "10.1016/j.ijid.2020.12.060_bib0110", "year": "2020" }, { "author": "Shanghai Public Health Clinical Center", "key": "10.1016/j.ijid.2020.12.060_bib0115", "series-title": "Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19", "year": "2020" }, { "DOI": "10.1186/1743-422X-2-69", "article-title": "Chloroquine is a potent inhibitor of SARS coronavirus infection and spread", "author": "Vincent", "doi-asserted-by": "crossref", "first-page": "69", "issue": "1", "journal-title": "Virol J", "key": "10.1016/j.ijid.2020.12.060_bib0120", "volume": "2", "year": "2005" }, { "author": "World Health Organization", "key": "10.1016/j.ijid.2020.12.060_bib0125", "series-title": "Solidarity\" clinical trial for COVID-19 treatments", "year": "2020" }, { "DOI": "10.1093/cid/ciaa237", "article-title": "In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "author": "Yao", "doi-asserted-by": "crossref", "journal-title": "Clin Infect Dis", "key": "10.1016/j.ijid.2020.12.060_bib0130", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", "author": "Zhou", "doi-asserted-by": "crossref", "first-page": "1054", "issue": "10229", "journal-title": "Lancet", "key": "10.1016/j.ijid.2020.12.060_bib0135", "volume": "395", "year": "2020" } ], "reference-count": 27, "references-count": 27, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1201971220325832" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Infectious Diseases", "Microbiology (medical)", "General Medicine" ], "subtitle": [], "title": "No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "104" }